Browsing: cancer
kyolshinShares of Arcus Biosciences (NYSE:RCUS) hit a new 52-week low on Tuesday after the biotech said that Gilead Sciences’ (NASDAQ:GILD)…
Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) announced Tuesday that the European Commission approved its anti-cancer agent Welireg (belzutifan) as a…
Rebeca Moen Feb 05, 2025 02:45BioTuring’s AI model offers detailed cellular visualizations of cancer, enhancing understanding of tumor dynamics and…
Mario TamaAn attorney representing the U.S. Department of Health & Human Services (HHS) said on Friday that the agency will…
Md Saiful Islam KhanPfizer (NYSE:PFE) announced Saturday that its colorectal cancer therapy Braftovi, as part of a combination regimen, reduced…
hapabapa/iStock Editorial via Getty ImagesBristol Myers Squibb (NYSE:BMY) announced Saturday that its checkpoint inhibitors Opdivo and Yervoy, when combined, reduced…
Mario Tama/Getty Images NewsThe U.S. Food and Drug Administration (FDA) has approved Amgen’s (NASDAQ:AMGN) KRASG12C inhibitor Lumakras as part of…
skynesher/E+ via Getty ImagesBall (NYSE:BALL) and Ardagh Metal Packaging (NYSE:AMBP) on Thursday were downgraded by analysts at financial-services firm Wells…
Xesai Clinical-stage biotech company Molecular Partners (NASDAQ:MOLN) and Orano Med, a clinical-stage radiopharmaceutical company expand their strategic collaboration. The terms…
MF3d/E+ via Getty Images Tenable Holdings (NASDAQ:TENB) Chair and Chief Executive Amit Yoran unexpectedly died on Friday, the cybersecurity company…